> GAMMAGARD S/D [Immune Globulin Intravenous (Human)], IgA less than 1 µ/mL in a 5% solution
GAMMAGARD S/D [Immune Globulin Intravenous (Human)], IgA less than 1 µ/mL in a 5% solution
Company : Baxter Healthcare Corp
UMDC Code : 453713
GAMMAGARD S/D is indicated for the treatment of primary immunodeficiency (PI) associated with defects in humoral immunity, in adults and children two years and older. This includes, but is not limited to, congenital agammaglobulinemia, common variable immunodeficiency, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies. GAMMAGARD S/D is also indicated for prevention of recurrent bacterial infections associated with B-cell Chronic Lymphocytic Leukemia (CLL), treatment of adult chronic Idiopathic Thrombocytopenic Purpura (ITP) to increase platelet count and to prevent and/or control bleeding, and prevention of coronary artery aneuryisms associated with Kawasaki Syndrome in pediatric patients.
Product URL : http://www.baxter.com/healthcare_professionals/pro
Last Updated : 03/16/2013